Business

Patrick J. McEnany Announces Intention to Retire as CEO of Catalyst Pharmaceuticals by Year-End

Mr. McEnany will Continue to Serve as Catalyst's Non-Executive Chairman of the Board Following his Retirement Nationally Recognized Executive Recruitment Firm

articleCatalyst Pharmaceuticals, Inc.July 25, 20233/company/catalyst-pharmaceuticals-inc/news/patrick-j-mcenany-announces-intention-to-retire-as-ceo-of-catalyst-pharmaceuticals
Patrick J. McEnany Announces Intention to Retire as CEO of Catalyst Pharmaceuticals by Year-End

About this update from Catalyst Pharmaceuticals, Inc.

[{"type":"text","content":"Mr. McEnany will Continue to Serve as Catalyst's Non-Executive Chairman of the Board Following his Retirement Nationally Recognized Executive Recruitment Firm has been Retained to Initiate Search CORAL GABLES, Fla., July 25, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (\"Catalyst\" or \"Company\") (Nasdaq: CPRX) today announced that Patrick J. McEnany, Catalyst’s Co-Founder, Chairman, and Chief Executive Officer (\"CEO\") has informed the Board of Directors (\"Board\") of his intention to retire from his position as CEO by the end of 2023. Mr. McEnany remains the Company’s largest individual stockholder and will continue to serve as CEO until his replacement is in place. Thereafter following his retirement as CEO, Mr. McEnany will continue to serve as non-Executive Chairman of Catalyst's Board of Directors. “I want to thank Pat for his tremendous contributions to Catalyst as our Company’s Co-Founder and CEO for the past 21 years,” said Charles O’Keeffe, Lead Independent Director for Catalyst. “Under his leadership, Catalyst has successfully transformed from a start-up into a formidable biopharmaceutical company specializing in bringing FDA approved therapies to patients suffering from rare neurological conditions. He has overseen highly strategic acquisitions and partnerships by Catalyst, fostered a high-performance culture and a highly engaged team of associates at Catalyst. His work has shaped and solidified the foundation from which our company will continue to build for the future. We look forward to Pat’s continued leadership and contribution as the Chairman of our Board of Directors.” “It has been an exceptional privilege to be the Co-Founder and CEO of Catalyst, which has provided me with the unique opportunity to oversee and actively contribute to the remarkable growth and substantial accomplishments that have driven our company’s success over the past two decades. I am incredibly proud of all we have achieved, and I look forward to continuing to serve as Chairman of the Board and helping guide our collective efforts for further growth,” stated Patrick J. McEnany, Co-Founder, Chairman, and CEO of Catalyst. “While I am looking forward to this next step, I want to thank our Board of Directors and my colleagues for their sustained partnership as we continue to deliver on the exceptional performance that is resha...

More updates from Catalyst Pharmaceuticals, Inc.